Page last updated: 2024-09-03

sr 11237 and Carcinoma, Embryonal

sr 11237 has been researched along with Carcinoma, Embryonal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Corbo, M; Gendimenico, GJ; Janssen, B; Mezick, JA; Stim, TB	1

Other Studies

1 other study(ies) available for sr 11237 and Carcinoma, Embryonal

Article	Year
A pleiotropic response is induced in F9 embryonal carcinoma cells and rhino mouse skin by All-trans-retinoic acid, a RAR agonist but not by SR11237, a RXR-selective agonist. The Journal of investigative dermatology, 1994, Volume: 102, Issue:5 Topics: Animals; Benzoates; Carcinoma, Embryonal; Cell Differentiation; Female; Male; Mice; Mice, Hairless; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Skin; Transcription Factors; Transcriptional Activation; Tretinoin; Tumor Cells, Cultured	1994

Article

Year

A pleiotropic response is induced in F9 embryonal carcinoma cells and rhino mouse skin by All-trans-retinoic acid, a RAR agonist but not by SR11237, a RXR-selective agonist.

The Journal of investigative dermatology, 1994, Volume: 102, Issue:5

Topics: Animals; Benzoates; Carcinoma, Embryonal; Cell Differentiation; Female; Male; Mice; Mice, Hairless; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Skin; Transcription Factors; Transcriptional Activation; Tretinoin; Tumor Cells, Cultured

1994